2016 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 3b. Estimated percent for time since first diagnosis among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.
| State/Territory | Sample size± |
5 or fewer years | More than 5 years | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
| Arizona | 358 | 36 | 12.2 | 3.3 | (5.7 – 18.7) | 322 | 87.8 | 3.3 | (81.3 – 94.3) |
| California | 265 | 31 | 11.3 | 2.5 | (6.4 – 16.2) | 234 | 88.7 | 2.5 | (83.8 – 93.6) |
| Connecticut | 317 | 38 | 11.5 | 2.4 | (6.8 – 16.2) | 279 | 88.5 | 2.4 | (83.8 – 93.2) |
| Florida | 978 | 135 | 16.3 | 3.0 | (10.4 – 22.2) | 843 | 83.7 | 3.0 | (77.8 – 89.6) |
| Georgia | 154 | 27 | 18.1 | 4.3 | (9.7 – 26.5) | 127 | 81.9 | 4.3 | (73.5 – 90.3) |
| Hawaii | 248 | 25 | N/A | N/A | (N/A – N/A) | 223 | 92.7 | 2.4 | (88.0 – 97.4) |
| Illinois | 176 | 20 | 12.8 | 3.8 | (5.4 – 20.2) | 156 | 87.2 | 3.8 | (79.8 – 94.6) |
| Indiana | 468 | 50 | 9.9 | 2.0 | (6.0 – 13.8) | 418 | 90.1 | 2.0 | (86.2 – 94.0) |
| Iowa | 189 | 31 | 18.9 | 4.7 | (9.7 – 28.1) | 158 | 81.1 | 4.7 | (71.9 – 90.3) |
| Kansas | 394 | 43 | 11.2 | 2.3 | (6.7 – 15.7) | 351 | 88.8 | 2.3 | (84.3 – 93.3) |
| Maine | 578 | 75 | 14.4 | 2.7 | (9.1 – 19.7) | 503 | 85.6 | 2.7 | (80.3 – 90.9) |
| Massachusetts | 217 | 24 | 16.0 | 3.9 | (8.4 – 23.6) | 193 | 84.0 | 3.9 | (76.4 – 91.6) |
| Michigan | 663 | 73 | 10.2 | 1.6 | (7.1 – 13.3) | 590 | 89.8 | 1.6 | (86.7 – 92.9) |
| Minnesota | 601 | 66 | 11.6 | 1.9 | (7.9 – 15.3) | 535 | 88.4 | 1.9 | (84.7 – 92.1) |
| Missouri | 280 | 25 | 6.6 | 1.7 | (3.3 – 9.9) | 255 | 93.4 | 1.7 | (90.1 – 96.7) |
| Montana | 194 | 20 | 8.5 | 2.4 | (3.8 – 13.2) | 174 | 91.5 | 2.4 | (86.8 – 96.2) |
| Nebraska | 472 | 53 | 8.2 | 1.7 | (4.9 – 11.5) | 419 | 91.8 | 1.7 | (88.5 – 95.1) |
| Nevada | 159 | 13 | N/A | N/A | (N/A – N/A) | 146 | 89.4 | 5.4 | (78.8 – 100.0) |
| New Hampshire | 221 | 20 | N/A | N/A | (N/A – N/A) | 201 | 90.3 | 3.5 | (83.4 – 97.2) |
| New Jersey | 290 | 37 | 12.1 | 2.7 | (6.8 – 17.4) | 253 | 87.9 | 2.7 | (82.6 – 93.2) |
| New Mexico | 210 | 28 | 13.5 | 3.7 | (6.2 – 20.8) | 182 | 86.5 | 3.7 | (79.2 – 93.8) |
| New York | 456 | 46 | N/A | N/A | (N/A – N/A) | 410 | 85.6 | 4.4 | (77.0 – 94.2) |
| Ohio | 451 | 61 | 15.6 | 3.2 | (9.3 – 21.9) | 390 | 84.4 | 3.2 | (78.1 – 90.7) |
| Oklahoma | 155 | 19 | N/A | N/A | (N/A – N/A) | 136 | 86.7 | 4.8 | (77.3 – 96.1) |
| Oregon | 166 | 12 | N/A | N/A | (N/A – N/A) | 154 | 92.4 | 2.5 | (87.5 – 97.3) |
| Pennsylvania | 263 | 32 | 10.5 | 2.6 | (5.4 – 15.6) | 231 | 89.5 | 2.6 | (84.4 – 94.6) |
| Rhode Island | 189 | 18 | N/A | N/A | (N/A – N/A) | 171 | 89.1 | 3.8 | (81.7 – 96.5) |
| Texas | 376 | 55 | 15.0 | 3.8 | (7.6 – 22.4) | 321 | 85.0 | 3.8 | (77.6 – 92.4) |
| Utah | 336 | 35 | 11.3 | 2.8 | (5.8 – 16.8) | 301 | 88.7 | 2.8 | (83.2 – 94.2) |
| Vermont | 246 | 27 | 8.8 | 2.2 | (4.5 – 13.1) | 219 | 91.2 | 2.2 | (86.9 – 95.5) |
| Wisconsin | 221 | 19 | N/A | N/A | (N/A – N/A) | 202 | 92.8 | 2.4 | (88.1 – 97.5) |
| Puerto Rico | 327 | 40 | 14.0 | 2.6 | (8.9 – 19.1) | 287 | 86.0 | 2.6 | (80.9 – 91.1) |
| 32 states / area | 10,618 | 1,234 | 12.6 | 0.8 | (11.0 – 14.2) | 9,384 | 87.4 | 0.8 | (85.8 – 89.0) |
| Median | 11.9 | 88.6 | |||||||
| Range | 6.6-18.9 | 81.1-93.4 | |||||||
1 Aged ≥ 18 years
2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon
Page last reviewed: February 19, 2020